You just read:

Prime Therapeutics Signs Outcomes-Based Contract with Novo Nordisk for Type 2 Diabetes Drug Victoza® (liraglutide)

News provided by

Prime Therapeutics LLC

Dec 08, 2017, 08:10 EST